Dangan, Gina .

HRN: 21-16-99  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2023
CEFUROXIME 1.5GM (VIAL)
09/23/2023
09/23/2023
IVT
1.5g
On Call To OR ANST
AUB Sec. To Uterine Myoma; G4P3 (3013)
Waiting Final Action 
09/23/2023
CEFUROXIME 1.5GM (VIAL)
09/23/2023
09/30/2023
IV
1.5gm
Q8 X 7 Days
Post OP Prophylaxis
Waiting Final Action 
09/24/2023
CEFUROXIME 500MG (TAB)
09/24/2023
09/30/2023
PO
500mg
BID
S/P Hysterectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: